Indomethacin reduces the risks of severe intraventricular hemorrhage*

https://doi.org/10.1016/S0022-3476(89)80300-2Get rights and content

A prospective, random selection, double-blind clinical trial was carried out to determine the efficacy of indomethacin in preventing periventricular-intraventricular hemorrhage (PV-IVH). Babies who were born in our institution, had birth weights ≤1500 gm, and had no PV-IVH or grade 1 PV-IVH were given either placebo (n=70) or indomethacin (n=71), 0.2 mg/kg intravenously at 6 hours of age and 0.1 mg/kg at 18 and 30 hours. Two major outcomes were determined: the development of grades 2 to 4 PV-IVH and the development of severe PV-IVH (i.e., hemorrhages with blood filling >50% of the ventricles and in some cases with associated parenchymal echodensities). Grades 2 to 4 PV-IVH occurred in 16 (23%) of the indomethacin group and 27 (39%) of the placebo group (p<0.03). The incidence of severe PV-IVH was 3% in the indomethacin-treated babies and 14% in the control group (p<0.02). The influence of other perinatal factors on the incidence of grades 2 to 4 or severe PV-IVH was determined by stepwise logistic regression. Placebo use, early grade 1 PV-IVH, lower birth weight, and higher fraction of inspired oxygen at 6 hours of life were associated with higher estimated odds of the development of grades 2 to 4 PV-IVH. Placebo use, male gender, lower 5-minute Apgar score, and a large base deficit were predictive of severe PV-IVH. Estimated odds ratios of severe PV-IVH with placebo use and male gender were 11.251 and 91, respectively. Thus indomethacin prophylaxis reduced the relative risk of grades 2 to 4 PV-IVH and severe PV-IVH, but other perinatal variables contributed significantly to the overall risk of PV-IVH.

References (37)

  • NagarajHS et al.

    Gastrointestinal perforation following indomethacin therapy in very-low-birth-weight infants

    J Pediatr Surg

    (1981)
  • MentLR et al.

    Randomized indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight infants

    J Pediatr

    (1985)
  • RennieJM et al.

    Early administration of indomethacin to preterm infants

    Arch Dis Child

    (1986)
  • Setzer-BandstraE et al.

    Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants

    Pediatrics

    (1988)
  • BadaHS et al.

    Germinal layer-intraventricular hemorrhage (GL/IVH) identified within five minutes of age

    Pediatr Res

    (1983)
  • KrishnamoorthyKS et al.

    Neurologic sequelae in the survivors of neonatal intraventricular hemorrhage

    Pediatrics

    (1979)
  • LazzaraA et al.

    Clinical predictability of intraventricular hemorrhage in preterm infants

    Pediatrics

    (1980)
  • ShankaranS et al.

    Sonographic classification of intraventricular hemorrhage: a prognostic indicator of mortality, morbidity, and short-term neurologic outcome

    Pediatrics

    (1982)
  • Cited by (94)

    • Acute Effects and Long-Term Consequences

      2018, The Newborn Lung: Neonatology Questions and Controversies, Third Edition
    • Intraventricular Hemorrhage and White Matter Injury in the Preterm Infant

      2018, Neurology: Neonatology Questions and Controversies
    • Prophylactic Indomethacin Revisited

      2017, Journal of Pediatrics
    • The effect of Indomethacin and Betamethasone on the cytokine response of human neonatal mononuclear cells to gram-positive bacteria

      2015, Cytokine
      Citation Excerpt :

      This drug has the ability to increase phagocytosis of monocytes and neutrophils and can also increase generation of superoxide ions in neutrophils [39,40] leading to increased bacterial clearance [41], which is a beneficial side effect when dealing with infection or sepsis. Furthermore, Indomethacin has been shown to decrease the risk of severe intraventricular hemorrhage [42] and reduce white matter injury [43]. The aim of the present study was to determine the impact of Betamethasone, Indomethacin and a combination therapy with both drugs on the fetal and neonatal immune system, in case of imminent preterm birth associated with intrauterine infection.

    • Intraventricular Hemorrhage and White Matter Injury in the Preterm Infant

      2012, Neurology: Neonatology Questions and Controversies Expert Consult - Online and Print
    View all citing articles on Scopus
    *

    Supported by National Institutes of Health (National Institute of Neurological and Communicative Disorders and Stroke) Program Project grant No. USPHS NS-21405.

    View full text